Financial Summary (All financials)
| In millions, except per share items | Dec-31-05 | Dec-31-04 | Dec-31-03 | Dec-31-02 |
| Revenues | 1,042.0 | 1,145.8 | 1,046.3 | 771.0 |
| Revenue growth | -9.1% | 9.5% | 35.7% | |
| Cost of goods sold | 781.2 | 799.7 | 704.2 | 623.4 |
| Gross profit | 260.8 | 346.1 | 342.1 | 147.6 |
| Gross margin | 25.0% | 30.2% | 32.7% | 19.1% |
| Selling, general and administrative | 180.5 | 209.0 | 213.3 | 189.9 |
| Research and development | 44.5 | 41.2 | 52.2 | 51.5 |
| EBIT | 39.2 | 92.6 | 78.6 | -157.9 |
| EBIT margin | 3.8% | 8.1% | 7.5% | -20.5% |
| Pre-tax income | 20.9 | 94.1 | 78.2 | -152.6 |
| Income taxes | -41.6 | 28.4 | 30.0 | -60.8 |
| Tax rate | | 30.2% | 38.4% | 39.8% |
| Net income | 62.5 | 65.7 | 48.2 | -91.8 |
| Net margin | 6.0% | 5.7% | 4.6% | -11.9% |
| |
| Diluted EPS | $0.85 | $0.89 | $0.66 | ($1.30) |
| Shares outstanding (diluted) | 73.6 | 73.5 | 72.7 | 70.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|